Synthesis, anti-HIV activity, integrase enzyme inhibition and molecular modeling of catechol, hydroquinone and quinol labdane analogs

2014 ◽  
Vol 24 (1) ◽  
pp. 302-307 ◽  
Author(s):  
Rohan Pawar ◽  
Tiyasa Das ◽  
Sanjay Mishra ◽  
Nutan ◽  
Boskey Pancholi ◽  
...  
2013 ◽  
Vol 8 (4) ◽  
pp. 452-464 ◽  
Author(s):  
Alejandro Speck-Planche ◽  
Valeria Kleandrova ◽  
Marcus Scotti ◽  
M. Cordeiro

2013 ◽  
Vol 23 (6) ◽  
pp. 2834-2846 ◽  
Author(s):  
Shobhitha Shetty ◽  
Balakrishna Kalluraya ◽  
Nithinchandra ◽  
S. K. Peethambar ◽  
Sandeep B. Telkar

2020 ◽  
Vol 16 (7) ◽  
pp. 938-946 ◽  
Author(s):  
Mahdieh Safakish ◽  
Zahra Hajimahdi ◽  
Rouhollah Vahabpour ◽  
Rezvan Zabihollahi ◽  
Afshin Zarghi

Introduction: Integrase is a validated drug target for anti-HIV-1 therapy. The second generation integrase inhibitors display π-stacking interaction ability with 3’-end nucleotide as a streamlined metal chelating pharmacophore. Method: In this study, we introduced benzoxazin-3-one scaffold for integrase inhibitory potential as bioisostere replacement strategy of 2-benzoxazolinone. Results: Molecular modeling studies revealed that amide functionality alongside oxadiazole heteroatoms and sulfur in the second position of oxadiazole ring could mimic the metal chelating pharmacophore. The halobenzyl ring occupies hydrophobic site created by the cytidylate nucleotide (DC-16). Conclusion: The most potent and selective compound displayed 110 μM IC50 with a selectivity index of more than 2.


2014 ◽  
Vol 5 (4) ◽  
pp. 588-594 ◽  
Author(s):  
Yossra Abood Marich ◽  
Niran Jassim Al-Salihi ◽  
Najim Aboud Al-Masoudi

2006 ◽  
Vol 49 (11) ◽  
pp. 3172-3184 ◽  
Author(s):  
Rino Ragno ◽  
Antonio Coluccia ◽  
Giuseppe La Regina ◽  
Gabriella De Martino ◽  
Francesco Piscitelli ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document